Examkin

Soru

Zorluk: Çok zorEndocrinology and Metabolism

A 34-year-old woman is evaluated for progressive weight gain, profound fatigue, and easy bruising over the past 8 months. Physical examination reveals facial plethora, marked central adiposity, supraclavicular fat pads, and wide violaceous abdominal striae. Her blood pressure is 158/96 mmHg. She takes no medications and has not used any exogenous glucocorticoids. Endogenous Cushing syndrome is suspected.

Arrange the following interventions in the most appropriate chronological sequence for the diagnostic workup and definitive management of this patient. Assume that the patient is ultimately proven to have Cushing disease caused by a biochemically active but radiologically equivocal (4-mm) pituitary microadenoma.

  1. 1Measurement of 24-hour urinary free cortisol
  2. 2Measurement of early morning plasma adrenocorticotropic hormone (ACTH)
  3. 3Magnetic resonance imaging (MRI) of the pituitary gland
  4. 4Inferior petrosal sinus sampling (IPSS) with corticotropin-releasing hormone (CRH) stimulation
  5. 5Transsphenoidal adenomectomy

Cevap

The correct sequential order for the diagnostic workup and management of Cushing disease is: (1) Measurement of 24-hour urinary free cortisol to establish hypercortisolism, (2) Measurement of early morning plasma ACTH to determine ACTH dependency, (3) MRI of the pituitary gland to localize the tumor, (4) Inferior petrosal sinus sampling to definitively confirm the central source of a microadenoma, and (5) Transsphenoidal adenomectomy as the definitive surgical treatment.
The evaluation of Cushing syndrome requires a rigid, stepwise algorithmic approach to prevent misdiagnosis. First, hypercortisolism must be proven biochemically (24-hour urine free cortisol). Second, the mechanism must be identified as ACTH-dependent or independent (plasma ACTH). Third, the source must be localized with imaging (pituitary MRI). Fourth, because the MRI finding in this scenario is less than 6 mm, it is considered radiologically equivocal due to the high population prevalence of pituitary incidentalomas; therefore, invasive confirmation with IPSS is mandatory. Finally, once IPSS confirms the pituitary as the source of ACTH, transsphenoidal adenomectomy is performed.

Adım Adım Çözüm

1
Measurement of 24-hour urinary free cortisol
Confirms the presence of pathological hypercortisolism.
Before any localizing tests, the biochemical presence of hypercortisolism must be definitively established to rule out physiologic variants or normal fluctuations.
2
Measurement of early morning plasma ACTH
Differentiates ACTH-independent from ACTH-dependent Cushing syndrome.
This determines whether the source of excess cortisol is primary adrenal (low ACTH) or driven by a central/ectopic source (high/normal ACTH).
3
Magnetic resonance imaging (MRI) of the pituitary gland
Attempts to visualize a pituitary adenoma.
Once an ACTH-dependent etiology is confirmed, the pituitary is the most likely source, making MRI the appropriate first-line imaging study.
4
Inferior petrosal sinus sampling (IPSS)
Confirms a central-to-peripheral ACTH gradient.
Because pituitary incidentalomas are found in up to 10% of healthy individuals, a lesion less than 6 mm is considered equivocal. IPSS is required to rule out ectopic ACTH secretion before proceeding to surgery.
5
Transsphenoidal adenomectomy
Resection of the pituitary adenoma and resolution of hypercortisolism.
This is the definitive therapeutic intervention once the pituitary source is unequivocally confirmed.

Anahtar Kavram

Algorithm for the step-wise biochemical diagnosis, radiological localization, and surgical management of endogenous Cushing syndrome.
Bu soruyu puanla

Konular

Endocrinology and Metabolism

Bu konudan daha fazla soru